-Mean absolute treatment difference in lung function across all patients was 2.1 percentage points (p=0.20) and mean relative treatment difference... ...http://www.asianhhm.com/press/pressrelease_archives.asp?PID=9080&title=Vertex-Announces-Results-of-Phase-3-Study-of-Ivacaftor-in-People-with-CF-who-have-the-R117H-Mutation
Sandoz, the generic pharmaceuticals division of Novartis, has received Danish marketing authorization for AirFluSal Forspiro, an innovative new... ...http://www.pharmabiz.com/NewsDetails.aspx?aid=79382&sid=2
The Delhi High Court has given a judicial magistrate three weeks to submit a report in a case where an eye and a part of the ear were found to be... ...http://www.indianexpress.com/news/parts-missing-from-body-of-convict-hc-seeks-report/1209761/
ESPOO, Finland, Dec. 19, 2013 (GLOBE NEWSWIRE) -- ORION CORPORATION STOCK EXCHANGE RELEASE 19 DECEMBER 2013 at 7.45 p.m. EET Orion Corporation... ...http://www.bizwireexpress.com/showstoryGNW.php?storyid=14229
Boheringer Inghelim has reported new pooled safety data from the RE-COVER and RE-COVER II phase III trials in acute deep vein thrombosis (DVT) and... ...http://www.pharmabiz.com/NewsDetails.aspx?aid=79357&sid=2
THIS SITE IS ABOUT THE MEDICAL...